Geovax Labs (GOVX)

$0.78 +0.05 (7.08%)
Market Cap 11.54M
Revenue (ttm) 3.95M
Net Income (ttm) -24.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -632.66%
Debt to Equity Ratio 0.00
Volume 476,100
Avg Vol 1,921,920
Day's Range N/A - N/A
Shares Out 15.93M
Stochastic %K 46%
Beta 3.27
Analysts Strong Sell
Price Target $10.38

Company Profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tu...

Industry: Biotechnology
Sector: Healthcare
Phone: (678) 384-7220
Fax: (678) 384-7281
Address:
1900 Lake Park Drive, Suite 380, Smyrna, United States
ChasingtheLambo
ChasingtheLambo Aug. 4 at 8:22 PM
$GOVX All BUY TO BUY!!!!!!
0 · Reply
AWIIII
AWIIII Aug. 4 at 4:33 PM
$MRNA Y'all heard about this? $GOVX $OCGN and I'll let longs at $BBAI know to be on the looks out.
5 · Reply
To_De_Moon
To_De_Moon Aug. 4 at 2:26 PM
$GOVX this needs to explode up
1 · Reply
stockoin
stockoin Aug. 4 at 12:09 PM
$GOVX Any MOU or agreement with African CDC countries will make a massive share price explosion
0 · Reply
BitcoinBankers
BitcoinBankers Aug. 4 at 8:18 AM
Ticker GYRO is exploding in pre-market!! Could GYRO be todays big squeeze?! news just released.. 700k shares float.. watchers on GYRO are growing very fast. Would not be surprised if GYRO is todays big 300% runner. 20$+ break could send her parabolic! $TNXP $GOVX $KCSE $DRMA news
0 · Reply
mendez628
mendez628 Aug. 1 at 8:43 PM
$GOVX 🤦‍♂️
1 · Reply
MGeronimo
MGeronimo Aug. 1 at 5:58 PM
$GOVX ADDED AT .74 great earnings
0 · Reply
Waffels
Waffels Jul. 31 at 8:26 PM
$GOVX i defeated severin this stock. it is bull territory. last time i seen him he was show me his new portfolio at burger king
0 · Reply
geniuscali
geniuscali Jul. 31 at 1:42 PM
$GOVX still wasting cash on covid??? https://www.cnbc.com/2025/07/31/moderna-to-slash-10percent-of-workforce-amid-covid-vaccine-sales.html
2 · Reply
Calvary316
Calvary316 Jul. 31 at 5:07 AM
$GOVX
0 · Reply
Latest News on GOVX
GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript

Jul 28, 2025, 7:43 PM EDT - 7 days ago

GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript

GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript

May 1, 2025, 8:58 PM EDT - 3 months ago

GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript

GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 8:53 PM EDT - 4 months ago

GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

Dec 9, 2024, 9:00 AM EST - 8 months ago

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

Nov 26, 2024, 9:00 AM EST - 9 months ago

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:33 PM EST - 9 months ago

GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 12, 2024, 4:00 PM EST - 9 months ago

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

Nov 5, 2024, 9:00 AM EST - 9 months ago

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Oct 2, 2024, 9:00 AM EDT - 10 months ago

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

GeoVax to Participate in Upcoming Investor Conferences in September

Sep 3, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Participate in Upcoming Investor Conferences in September

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

Aug 28, 2024, 8:59 PM EDT - 1 year ago

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

GeoVax's stock slides 20% after company raises $8.5 million in stock sale

Aug 20, 2024, 8:09 AM EDT - 1 year ago

GeoVax's stock slides 20% after company raises $8.5 million in stock sale

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

Aug 20, 2024, 7:45 AM EDT - 1 year ago

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

Aug 20, 2024, 7:00 AM EDT - 1 year ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GDTC GOSS IMRN

GeoVax's stock soars 54% to lead rally in companies developing mpox treatments

Aug 19, 2024, 7:30 AM EDT - 1 year ago

GeoVax's stock soars 54% to lead rally in companies developing mpox treatments

GeoVax to Present at the Emerging Growth Conference on August 21, 2024

Aug 15, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present at the Emerging Growth Conference on August 21, 2024

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

Aug 15, 2024, 8:36 AM EDT - 1 year ago

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

EBS SIGA

GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 6:15 AM EDT - 1 year ago

GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call Transcript

GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

Aug 8, 2024, 9:00 AM EDT - 1 year ago

GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 6, 2024, 4:00 PM EDT - 1 year ago

GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update

Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review

Jul 31, 2024, 10:15 AM EDT - 1 year ago

Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review

GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript

May 14, 2024, 8:01 PM EDT - 1 year ago

GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine

Apr 4, 2024, 12:30 PM EDT - 1 year ago

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine

GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress

Mar 28, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress

GeoVax to Present at the 36th Annual Roth Conference

Mar 12, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present at the 36th Annual Roth Conference

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

Mar 6, 2024, 9:00 AM EST - 1 year ago

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript

Mar 1, 2024, 2:34 AM EST - 1 year ago

GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

Feb 29, 2024, 4:00 PM EST - 1 year ago

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024

Feb 22, 2024, 9:00 AM EST - 1 year ago

GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024

GeoVax to Present at the 2024 BIO CEO & Investor Conference

Feb 19, 2024, 9:00 AM EST - 1 year ago

GeoVax to Present at the 2024 BIO CEO & Investor Conference

GeoVax Announces Multiple Patent Issuances and Allowances

Feb 13, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Multiple Patent Issuances and Allowances

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster

Feb 6, 2024, 9:00 AM EST - 1 year ago

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster

GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

Jan 29, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

Jan 8, 2024, 9:00 AM EST - 1 year ago

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

Jan 4, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

GeoVax Announces Issuance of Malaria Vaccine Patent

Jan 3, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Issuance of Malaria Vaccine Patent

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

Dec 27, 2023, 9:00 AM EST - 1 year ago

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox

Dec 19, 2023, 9:00 AM EST - 1 year ago

GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox

GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress

Nov 30, 2023, 4:30 PM EST - 1 year ago

GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress

GeoVax to Participate in Upcoming December Investor Events

Nov 29, 2023, 9:00 AM EST - 1 year ago

GeoVax to Participate in Upcoming December Investor Events

GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress

Nov 28, 2023, 9:00 AM EST - 1 year ago

GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress

Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023

Nov 14, 2023, 9:00 AM EST - 1 year ago

Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023

GeoVax Labs, Inc. (GOVX) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 9:26 PM EST - 1 year ago

GeoVax Labs, Inc. (GOVX) Q3 2023 Earnings Call Transcript

GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 8, 2023, 4:00 PM EST - 1 year ago

GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update

GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine

Oct 30, 2023, 9:00 AM EDT - 1 year ago

GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine

GeoVax to Participate in Upcoming November Investor and Industry Events

Oct 25, 2023, 9:00 AM EDT - 1 year ago

GeoVax to Participate in Upcoming November Investor and Industry Events

GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities

Oct 24, 2023, 9:00 AM EDT - 1 year ago

GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities

GeoVax Receives Notice of Allowance for Marburg Vaccine Patent

Oct 9, 2023, 9:00 AM EDT - 1 year ago

GeoVax Receives Notice of Allowance for Marburg Vaccine Patent

GeoVax Receives Notice of Allowance for HIV Vaccine Patent

Oct 5, 2023, 9:00 AM EDT - 1 year ago

GeoVax Receives Notice of Allowance for HIV Vaccine Patent

GeoVax to Participate in Upcoming October Investor and Industry Events

Sep 27, 2023, 9:00 AM EDT - 2 years ago

GeoVax to Participate in Upcoming October Investor and Industry Events

ChasingtheLambo
ChasingtheLambo Aug. 4 at 8:22 PM
$GOVX All BUY TO BUY!!!!!!
0 · Reply
AWIIII
AWIIII Aug. 4 at 4:33 PM
$MRNA Y'all heard about this? $GOVX $OCGN and I'll let longs at $BBAI know to be on the looks out.
5 · Reply
To_De_Moon
To_De_Moon Aug. 4 at 2:26 PM
$GOVX this needs to explode up
1 · Reply
stockoin
stockoin Aug. 4 at 12:09 PM
$GOVX Any MOU or agreement with African CDC countries will make a massive share price explosion
0 · Reply
BitcoinBankers
BitcoinBankers Aug. 4 at 8:18 AM
Ticker GYRO is exploding in pre-market!! Could GYRO be todays big squeeze?! news just released.. 700k shares float.. watchers on GYRO are growing very fast. Would not be surprised if GYRO is todays big 300% runner. 20$+ break could send her parabolic! $TNXP $GOVX $KCSE $DRMA news
0 · Reply
mendez628
mendez628 Aug. 1 at 8:43 PM
$GOVX 🤦‍♂️
1 · Reply
MGeronimo
MGeronimo Aug. 1 at 5:58 PM
$GOVX ADDED AT .74 great earnings
0 · Reply
Waffels
Waffels Jul. 31 at 8:26 PM
$GOVX i defeated severin this stock. it is bull territory. last time i seen him he was show me his new portfolio at burger king
0 · Reply
geniuscali
geniuscali Jul. 31 at 1:42 PM
$GOVX still wasting cash on covid??? https://www.cnbc.com/2025/07/31/moderna-to-slash-10percent-of-workforce-amid-covid-vaccine-sales.html
2 · Reply
Calvary316
Calvary316 Jul. 31 at 5:07 AM
$GOVX
0 · Reply
Calvary316
Calvary316 Jul. 31 at 5:04 AM
$GOVX
0 · Reply
Calvary316
Calvary316 Jul. 31 at 5:04 AM
$GOVX
1 · Reply
Calvary316
Calvary316 Jul. 31 at 5:03 AM
$GOVX
0 · Reply
DavidScott
DavidScott Jul. 31 at 3:38 AM
On watch tomorrow (swing trading) // Part 2 🔥📈📚 $FUBO $SIDU $BULL $GOVX $CLOV
0 · Reply
Calvary316
Calvary316 Jul. 30 at 6:48 PM
$GOVX
1 · Reply
Calvary316
Calvary316 Jul. 30 at 6:47 PM
$GOVX Started a Position here
0 · Reply
To_De_Moon
To_De_Moon Jul. 30 at 4:37 PM
$GOVX $OCGN lets go
0 · Reply
Radioskeptic
Radioskeptic Jul. 30 at 3:37 PM
$GOVX Click on "All" on the chart timing above. This has reverse split so many times it's unbelievable. All investors have done over these years is pay the salaries of the staff. These people are crooks. It was never $40,000,000.00 a share.
1 · Reply
Trader_Tom
Trader_Tom Jul. 30 at 2:09 PM
$MBRX New patent news $XBP $BGLC $GOVX $REPL
0 · Reply
mendez628
mendez628 Jul. 30 at 11:06 AM
$GLXG $GRI $GOVX whole market was down yesterday. Will we see a rebound today?
0 · Reply
DavidScott
DavidScott Jul. 30 at 3:34 AM
On watch tomorrow (swing trading) // Part 2 🔥📈📚 $FUBO $LUMN $GOVX $NNDM $GME
1 · Reply
lealbinagor98
lealbinagor98 Jul. 30 at 12:44 AM
$GOVX let's up coming soon 🚀🔥⏰️👋 $SCLX $CHRS $NVAX
0 · Reply